ChromaDex (CDXC)
(Delayed Data from NSDQ)
$5.51 USD
+0.03 (0.55%)
Updated Jan 3, 2025 04:00 PM ET
After-Market: $5.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/05/2025
Time: -- |
12/2024 | $0.02 | 0.00% |
Earnings Summary
For their last quarter, ChromaDex (CDXC) reported earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This reflects a positive earnings surprise of 100.00%. Look out for CDXC's next earnings release expected on March 05, 2025.
Earnings History
Price & Consensus
Zacks News for CDXC
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
CDXC: What are Zacks experts saying now?
Zacks Private Portfolio Services
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable
ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?
Recent Price Trend in ChromaDex (CDXC) is Your Friend, Here's Why
CDXC FAQs
ChromaDex Corporation (CDXC) has announced they will report their next quarter earnings on March 05, 2025. For the next earning release, we expect the company to report earnings of $0.02 per share, reflecting a year-over-year decrease of %.
ChromaDex Corporation has announced they will report their previous quarter earnings after the close of the market on March 05, 2025.
The Zacks Consensus Estimate for ChromaDex Corporation (CDXC) for the quarter ending December 2024 is $0.02 a share. We expect ChromaDex Corporation (CDXC) to report earnings in line with the consensus estimate of $0.02 per share
In the earnings report for the quarter ending in September 2024, ChromaDex Corporation (CDXC) announced earnings of $0.02 per share versus the Zacks Consensus Estimate of $0.01 per share, representing a surprise of 100.00%.